SCHEMBL700359

SCHEMBL700359

Cc1cccc([C@H](C)c2nccn2C(=O)OCc2ccc(F)cc2Cl)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 1/20 0.45
ALOX15 P16050 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 1/20 0.37
POLB P06746 2/20 0.37
P2RX7 Q99572 5/20 0.36
KMT2A Q03164 3/20 0.36
PTGER1 P34995 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
DUSP3 P51452 1/20 0.34
PTPN5 P54829 1/20 0.34
PTPN11 Q06124 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL697431 0.91 MAPK14 (0.39) L3MBTL1ALDH1A1KMT2APTGER1MEN1
SCHEMBL696841 0.90 FFAR1 (0.37) L3MBTL1ALDH1A1ALOX15NPSR1HSD17B10
SCHEMBL698596 0.89 MMP2 (0.38) L3MBTL1ALDH1A1POLBPTGER1
SCHEMBL713262 0.88 KDM5A (0.36) L3MBTL1ALDH1A1MAPTPOLBKMT2A
SCHEMBL713263 0.88 KDM5A (0.36) L3MBTL1ALDH1A1MAPTPOLBKMT2A
SCHEMBL696969 0.88 CASP3 (0.39) ALDH1A1NPSR1HTTMAPTPOLB
SCHEMBL698746 0.87 PTGER1 (0.37) PTGER1CYP1A2CYP2C9CYP2C19
SCHEMBL3533877 0.85 SCN5A (0.40) L3MBTL1SMN1; SMN2MAPTKMT2ACYP1A2
SCHEMBL698052 0.85 KCNH2 (0.36) ALDH1A1HTTMAPTP2RX7KMT2A
SCHEMBL697361 0.85 GRIN2B (0.41) MAPTCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 L3MBTL1 1548/4885ALDH1A1 617/4885ALOX15 4647/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 L3MBTL1 1548/4885ALDH1A1 617/4885ALOX15 4647/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 L3MBTL1 1548/4885ALDH1A1 617/4885ALOX15 4647/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 L3MBTL1 1548/4885ALDH1A1 617/4885ALOX15 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.